Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

262 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Reinfusion of unprocessed, granulocyte colony-stimulating factor-stimulated whole blood allows dose escalation of 186Relabeled chimeric monoclonal antibody U36 radioimmunotherapy in a phase I dose escalation study.
Colnot DR, Ossenkoppele GJ, Roos JC, Quak JJ, de Bree R, Börjesson PK, Huijgens PC, Snow GB, van Dongen GA. Colnot DR, et al. Among authors: huijgens pc. Clin Cancer Res. 2002 Nov;8(11):3401-6. Clin Cancer Res. 2002. PMID: 12429627 Clinical Trial.
Granulocyte colony-stimulating factor mobilized whole blood containing over 0.3 x 106/kg CD34+ cells is a sufficient graft in autologous transplantation for relapsed non-Hodgkin's lymphoma.
Jonkhoff AR, De Kreuk AM, Franschman G, Van Der Lelie J, Schuurhuis GJ, Dräger AM, Zweegman S, Huijgens PC, Ossenkoppele GJ. Jonkhoff AR, et al. Among authors: huijgens pc. Br J Haematol. 2002 Jul;118(1):90-100. doi: 10.1046/j.1365-2141.2002.03636.x. Br J Haematol. 2002. PMID: 12100131 Free article.
Biodistribution, radiation dosimetry and scouting of 90Y-ibritumomab tiuxetan therapy in patients with relapsed B-cell non-Hodgkin's lymphoma using 89Zr-ibritumomab tiuxetan and PET.
Rizvi SN, Visser OJ, Vosjan MJ, van Lingen A, Hoekstra OS, Zijlstra JM, Huijgens PC, van Dongen GA, Lubberink M. Rizvi SN, et al. Among authors: huijgens pc. Eur J Nucl Med Mol Imaging. 2012 Mar;39(3):512-20. doi: 10.1007/s00259-011-2008-5. Epub 2012 Jan 5. Eur J Nucl Med Mol Imaging. 2012. PMID: 22218876 Free PMC article. Clinical Trial.
Autologous Stem Cell Transplantation in elderly Acute Myeloid Leukemia.
Ossenkoppele GJ, Janssen JJ, Huijgens PC. Ossenkoppele GJ, et al. Among authors: huijgens pc. Mediterr J Hematol Infect Dis. 2013;5(1):e2013018. doi: 10.4084/MJHID.2013.018. Epub 2013 Feb 16. Mediterr J Hematol Infect Dis. 2013. PMID: 23505606 Free PMC article.
High prognostic impact of flow cytometric minimal residual disease detection in acute myeloid leukemia: data from the HOVON/SAKK AML 42A study.
Terwijn M, van Putten WL, Kelder A, van der Velden VH, Brooimans RA, Pabst T, Maertens J, Boeckx N, de Greef GE, Valk PJ, Preijers FW, Huijgens PC, Dräger AM, Schanz U, Jongen-Lavrecic M, Biemond BJ, Passweg JR, van Gelder M, Wijermans P, Graux C, Bargetzi M, Legdeur MC, Kuball J, de Weerdt O, Chalandon Y, Hess U, Verdonck LF, Gratama JW, Oussoren YJ, Scholten WJ, Slomp J, Snel AN, Vekemans MC, Löwenberg B, Ossenkoppele GJ, Schuurhuis GJ. Terwijn M, et al. Among authors: huijgens pc. J Clin Oncol. 2013 Nov 1;31(31):3889-97. doi: 10.1200/JCO.2012.45.9628. Epub 2013 Sep 23. J Clin Oncol. 2013. PMID: 24062400 Clinical Trial.
262 results